SK C&C Turns to AI for New Drug Development
SEOUL, Sept. 7 (Korea Bizwire) — SK C&C Co., an IT service unit of South Korean conglomerate SK Group, said Monday it had expanded the application area of its artificial intelligence (AI)-based target identification platform to include non-alcoholic fatty liver disease. The platform, originally intended for the development of new drugs for metabolic diseases, was [...]